论文部分内容阅读
本文对152例肝病和56例非肝病患者血清中HBsAg和抗—HCV标志进行研究的结果表明:肝病组HBsAg阳性率为82.9％,其中肝癌、肝硬变、慢重肝、慢活肝、慢迁肝和急性肝炎的阳性率分别为96.3％、95.2％、100％、95.7％、90.9％和28.6％,对照组为21.4％。肝病组抗—HCV阳性率为17.1％。上述各型肝病的抗—HCV阳性率分别为40.7％、23.8％、37.5％、13.0％、4.5％和0.0％,抗—HCV阳性者均为HBsAg阳性,对照组为0.0％。研究结果提示;HBV感染是广西慢性肝病主要病因,HCV次之,两者合并感染其预后较差。
In this paper, 152 cases of liver disease and 56 cases of non-liver disease serum HBsAg and anti-HCV markers study showed that: liver disease group HBsAg positive rate was 82.9%, including liver cancer, cirrhosis, chronic severe liver, slow liver, slow The positive rates of liver metastasis and acute hepatitis were 96.3%, 95.2%, 100%, 95.7%, 90.9% and 28.6% respectively, and 21.4% in the control group. The positive rate of anti-HCV in liver disease group was 17.1%. The positive rates of anti-HCV in all kinds of liver diseases were 40.7%, 23.8%, 37.5%, 13.0%, 4.5% and 0.0% respectively. The anti-HCV positives were both HBsAg positive and control group was 0.0%. The results suggest that HBV infection is the main cause of chronic liver disease in Guangxi, followed by HCV, the combination of the two prognosis is poor.